$9m in ARC grants released
Tuesday, 03 June, 2003
Some of Australia's best-known biotechs -- including Biota, Gradipore, Amrad, Proteome Systems, Nanomics, Starpharma and PanVax -- will benefit from the latest round of Australian Research Council linkage grants.
Life science projects picked up $9 million of the total $47.5 million on offer.
Linkage grants support the development of strategic research alliances with industry. Companies provide $1.64 for every $1 spent by the Commonwealth.
Prof Alan Johnson, executive director of biological sciences and biotechnology for the ARC, said the linkage scheme had been a success, particularly since the move to offer two rounds of funding per year. "Successful recipients can get going faster," he said.
Big pharma also takes part -- Novartis Animal Health and GlaxoSmithKline are industry partners this round. And industry organisation AusBiotech is also a participant in two grants looking at commercialisation strategies and comparisons between biotechnology, nanotechnology and the information technology industries.
Widespread resistance to common antibiotics is increasing: WHO
Increasing resistance to essential antibiotics poses a growing threat to global health, with one...
Dopamine helps our brains to let go of memories
In a discovery that could reshape how we think about memory, researchers at Flinders University...
Vaccine for elephant herpesvirus found to be safe
The vaccine could prevent deadly elephant endotheliotropic herpesvirus in calves — the...
